Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

BACKGROUND: To investigate the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors on renal outcomes in patients with type 2 diabetes. METHODS: MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were searched to identify randomized controlled trials (RCTs) of DPP-4 inhibitors f...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocrinol Metab (Seoul)
Autors principals: Bae, Jae Hyun, Kim, Sunhee, Park, Eun-Gee, Kim, Sin Gon, Hahn, Seokyung, Kim, Nam Hoon
Format: Artigo
Idioma:Inglês
Publicat: Korean Endocrine Society 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6435854/
https://ncbi.nlm.nih.gov/pubmed/30912341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2019.34.1.80
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars